Cleared Special

K062140 - SURGIFROST XL CRYOSURGICAL DEVICE, MODEL 60SFXL

Also marketed or referenced as:
CRYOSURGICAL CONSOLE, MODEL 65CS1

K062140 is an FDA 510(k) clearance for SURGIFROST XL CRYOSURGICAL DEVICE, manufactured by Cryocath Technologies, Inc.. The device is a Class 2 Cardiovascular device with product code OCL cleared through the Special 510(k) pathway after a 28-day FDA review.

K062140 · Cryocath Technologies, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2006
Decision
28d
Days
Class 2
Risk

K062140 is an FDA 510(k) clearance for the SURGIFROST XL CRYOSURGICAL DEVICE, MODEL 60SFXL. Classified as Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue (product code OCL), Class II - Special Controls.

Submitted by Cryocath Technologies, Inc. (Brookline, US). The FDA issued a Cleared decision on August 24, 2006 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 878.4400 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Cryocath Technologies, Inc. devices

FDA 510(k) Submission Details - K062140

510(k) Number K062140 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 27, 2006
Decision Date August 24, 2006
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

OCL Device Classification - Class 2, Special Controls

Product Code OCL Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Surgical Device For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - OCL Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue

All 39
Devices cleared under the same product code (OCL) and FDA review panel - the closest regulatory comparables to K062140.
ATRICURE COOLRAIL LINEAR PEN
K073605 · AtriCure, Inc. · Mar 2008
ATRICURE BIPOLAR SYSTEM
K043579 · AtriCure, Inc. · Jul 2007
CARDIOBLATE MONOPOLAR PEN, 60813, CARDIOBLATE MONOPOLAR XL, 60814
K070288 · Medtronic Vascular · Jun 2007
ATRICURE ISOLATOR TRANSPOLAR PEN SYSTEM, MODELS ASU2, MAX1, MAX2 AND ASB1
K061593 · AtriCure, Inc. · Jul 2006
ATRICURE ISOLATOR TRANSPOLAR PEN
K050459 · AtriCure, Inc. · Jun 2005
MODIFIED CARDIAC CRYOSURGICAL SYSTEM, MODELS 6TCS1 & 6TCSE
K021010 · Endocare, Inc. · Jun 2002